07:00 , Sep 15, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer B cell lymphoma ATP-binding cassette sub-family A member 3 (ABCA3) Cell culture studies suggest inhibiting ABCA3 could increase the efficacy of anti-CD20 therapies for B...